loader image

The only escape he should be experiencing

Evaluate effective testosterone suppression in your patients' GnRH therapy.

Measure

  • Many men experience testosterone breakthroughs while on androgen deprivation therapy (ADT)10-14
  • Testosterone breakthroughs produce PSA increases, mimicking progression to castrate-resistant prostate cancer (CRPC)10-14
  • Neglecting to assess testosterone will fail to identify levels above the desired target throughout the dosing period, including microsurges, and escapes15
  • Testosterone (T) levels should be measured regularly in men receiving ADT to ensure T suppression is being maintained to target5
  • Adding a testosterone test to regular prostate-specific antigen (PSA) assessment is simple to implement and can help address these concerns15

Measuring testosterone levels helps to assess if biochemical castration has been achieved and maintained.5

  • Many men experience testosterone breakthroughs while on androgen deprivation therapy (ADT)10-14
  • Testosterone breakthroughs produce PSA increases, mimicking progression to castrate-resistant prostate cancer (CRPC)10-14
  • Neglecting to assess testosterone will fail to identify levels above the desired target throughout the dosing period, including microsurges, and escapes15
  • Testosterone (T) levels should be measured regularly in men receiving ADT to ensure T suppression is being maintained to target5
  • Adding a testosterone test to regular prostate-specific antigen (PSA) assessment is simple to implement and can help address these concerns15

ACT

  • Trelstar lowered testosterone below castration levels*
  • Consistent testosterone and PSA suppression regardless of strength7
  • Fewer testosterone breakthroughs than Lupron® in a head-to-head study2

Prescribe Trelstar for reliable testosterone suppression.

  • Trelstar lowered testosterone below castration levels*
  • Consistent testosterone and PSA suppression regardless of strength7
  • Fewer testosterone breakthroughs than Lupron® in a head-to-head study2

IS YOUR PROSTATE CANCER PATIENT Agonist Deficient?

Study Design

The 3.75 mg data are based on a 9-month, multicenter, parallel-group, blindly randomized, controlled clinical trial comparing Trelstar® mg to leuprolide acetate in patients with advanced (stage C/D) prostate cancer (N=284). Mean testosterone levels were calculated for months 2 to 9.

Order Trelstar from AndaMEDS

Trelstar can be ordered directly from our national specialty distributor, AndaMEDS, which provides next business day delivery and other convenient benefits. Call AndaMEDS at 1.855.468.5649, ext.74453.

 

If you already have a Trelstar account with AndaMEDS®, please click here or register at www.andameds.com.

Thank you for visiting.

You are now leaving a Verity website. A link to a non-Verity website does not constitute an endorsement of the products or services offered by the non-Verity website, and Verity is not responsible for the content of any non-Verity website.

Healthcare Professionals

The information contained in this website is intended for US Healthcare professionals only.